GoodRx (GDRX) director reports 104,925 RSUs, 33,530 RSUs added
GoodRx (GDRX) director Trevor Bezdek reported equity awards and updated holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GoodRx (GDRX) director Trevor Bezdek reported equity awards and updated holdings. On 11/02/2025, he received 104,925 restricted stock units (RSUs) at $0 that vest in three equal installments beginning 11/02/2026. He also acquired 33,530 RSUs at $0 that vest in full on the earlier of June 3, 2026 or the 2026 annual meeting, subject to continued service.
Following the transactions, he beneficially owned 160,082 Class A shares directly. Indirect holdings were listed as 2,632,721 shares by TB 2024-2 GRAT and 2,632,721 shares by JB 2024-2 GRAT.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 104,925 | $0.00 | $0.00 |
| Grant/Award | Class A Common Stock | 33,530 | $0.00 | $0.00 |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (5)
- F1. Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 3, 2026 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.
- F2. Share held directly by TB 2024 -2 GRAT, a grantor retained annuity trust (the "TB 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT.
- F3. Share held directly by JB 2024-2 GRAT, a grantor retained annuity trust (the "JB 2024-2 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the TB 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
- F4. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- F5. The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 2, 2026, subject to continued service through the applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did GoodRx (GDRX) disclose in this Form 4?
How do the 104,925 RSUs for GDRX vest?
When do the 33,530 RSUs for GDRX vest?
What indirect GDRX holdings were reported?
What is the transaction date for the reported GDRX awards?
AI-generated analysis. How Rhea-AI works. Not financial advice.